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ABSTRACT
Purpose: To investigate the effect of ACE inhibitor, lisinopril and AT1 blocker, losartan, on the obstructive pancreatitis in rat.
Methods: Acute pancreatitis in rats (n=21) was induced for a common hepatic duct were ligated proximal to its entry into the pancreas
and the common bile - pancreatic duct were also ligated near its junction with the duodenum, under ether anesthesia, after which the
abdomen were closed. The animals was divided in tree groups, being two treated and control group. The animals was treated with
Losartan and Lisinopril at the dose of 10µg/Kg body weight per day, i.p., in a proportional volume, for five days, before and after
treatement. Results: The inflammation, collagen deposition in the pancreas of treated animals were smaller, suggesting that the use of
antihypertensive agents interfered positively in the depletion of the injury of the pancreas. Scythe showed a correlation between activity
of pancreatic stellate cells (PSCs) lower in treated animals when compared to control. Conclusion: The pancreatic stellate cells strength
are involved in collagen production during acute pancreatitis and why antihypertensive drugs such as lisinopril and losartan may
possibly have beneficial effects in reducing pancreatic fibrosis in models of experimental obstructive pancreatitis.
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RESUMO
Objetivo: Investigar o efeito de um inibidor da ECA, lisinopril e bloqueador AT1, losartan, a pancreatite obstrutiva em ratos.
Métodos: Pancreatite aguda em ratos (n = 21) foi induzida por um ducto hepático comum foram ligados proximal à sua entrada no
pâncreas e da bílis comum - ducto pancreático também foram ligados perto de sua junção com o duodeno, sob anestesia com éter,
após o que abdome foram fechadas. Os animais foram divididos em três grupos, sendo dois tratados eo grupo controle. Os animais foram
tratados com lisinopril e losartan na dose de 10µg/Kg de peso corporal por dia, IP, em um volume proporcional, por cinco dias, antes e
depois do tratamento com. Resultados: A inflamação, deposição de colágeno no pâncreas de animais tratados foram menores, sugerindo
que o uso de agentes anti-hipertensivos interferiram positivamente na diminuição da lesão do pâncreas. Este estudo mostrou uma
correlação entre a atividade das células pancreáticas estreladas (CSP) menor nos animais tratados quando comparados ao
control.Conclusão: A força das células pancreáticas estreladas está envolvida na produção de colágeno durante a pancreatite aguda e por
medicamentos anti-hipertensivos, tais como lisinopril e losartan pode eventualmente ter efeitos benéficos na redução da fibrose do
pâncreas em modelos experimentais de pancreatite obstrutiva.
Descritores: Pancreatite. Receptores de Angiotensina. Anti-Hipertensivos. Ratos.
1Research performed at the Pathology Molecular Laboratory and Post-graduation Program, Department of Pathology and Forensis Medicine, Faculty
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Introduction
Acute pancreat i t is  is  a  severe human disease
characterized by acinar cell necrosis, extensive interstitial edema
and migration of neutrophils into the damaged gland1. The
etiology of acute pancreatitis has been considered to be
multifactorial, although difference in the triggering mechanisms
end up with the same common pathway2. The current knowledge
shows that the activation of digestive zymogens inside the acinar
cells leads to acinar cell injury3. Through the autodigestion of
pancreatic tissue by the premature activation of proenzymes prior
to their release into the duodenum4. Some of the crucial factors
may include activation of proteolytic enzymes, lipase, kinins and
others vasoactives peptides such as angiotensin II1,5. Recent
investigations suggested that the ultimate severity of pancreatitis
was determined by events that occurred subsequently to acinar cell
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injury, including inflammatory cell recruitment and the release of
cytokines and other chemotactic mediators of inflammation6.
Renin-angiotensin system (RAS) has been identified to
participate in inflammatory events. The local increase in vascular
permeability and recrutament of inflammatory cells to the site of
injury by the action of inflammatory cytokines is a critical step in
the progression of inflammation7. The effect of angiotesin II
stimulating the synthesis and secretion of vascular permeability
factor, synthesis of adhesion molecules and chemokines as well as
the migration and adhesion of monocytes and leukocytes8 has
been demonstraded. The angiotensin II and AT1 and AT2 receptors
have been localized in the microcirculation and epithelium of the
ductal system in rodent and human  pancreas9.
Some pancreatic cells have recently been identified,
isolated and termed pancreatic stellate cells (PSCs) once they
exhibit morphological and functional features similar to cultured
hepatic stellate cells10,11. PSCs are activated in both experimental
and human pancreatic fibrosis by RAS and are the main cellular
source of collagen in chronic pancreatitis. Other studies suggest
that PSCs play an important role in pancreatic fibrogenesis5.
The PSCs are involved in the pathogenesis of chronic
pancreatitis, they even can be considered to be therapeutic targets
for the suppression of acute pancreatitis. On the other hand, biliar
obstruction is the main cause of human pancreatitis and this model
could be easily reproduced in rats by the ligature of the bilio –
pancreatic duct.
Anti –hypertensive drugs have been accepted beneficial
effects on acute and chronic pancreatitis12. Therefore, the purpose
of the present study is to investigate the effect of ACE inhibitor,
lisinopril and AT1 blocker, losartan, on the obstructive pancreatitis
in rat.
Methods
The study was previously approved by the Ethics
Committee for Animal Research of the Faculty Medicine of Ribeirao
Preto – University of Sao Paulo. Male Wistar rats had been housed
in a temperature-controlled room with 12-h light-dark cycle and
received standard laboratory chow (Purina) and water ad libitum.
All animals had been treated according to the International
Guiding Principles for Biomedical Research Involving Animals.
The body weight of the animals was 200±15g at the time of
surgery. Rats were allocated to one of three groups. In the first
group (n=7) the animals were treated daily with saline solution,
intraperitoneally (i.p.), for five days. Then the common hepatic
duct were ligated proximal to its entry into the pancreas and the
common bile - pancreatic duct were also ligated near its junction
with the duodenum, under ether anesthesia, after which the
abdomen were closed13. After that the animals received saline
solution, i.p., daily, for more five days, Control Group (CG). The
second group (n=7) were treated daily with losartan (Merk, Sharp
& Dohme, Rahway, NJ, U.S.A) at the dose of 10µg/Kg body weight
per day, i.p., in a proportional volume, for five days. These animals
were subjected to the same surgical procedure and treated with
losartan, Losartan Group (LOG), i.p., for more five days. The third
group (n=7) were treated daily with lisinopril (Merk, Sharp &
Dohme, Rahway, NJ, U.S.A) at the dose of 10µg/Kg body weight
per day i.p., in a proportional volume, for five days. These animals
were subjected to the same surgical procedure and treated with
lisinopril, Lisinopril Group (LIG), i.p., for more five days. Then,
the animals of all the groups were sacrificed under ether
anesthesia.
Histological studies
Paraffin sections of rat pancreatic tissue were stained by
hematoxylin and eosin and for collagen using Sirius – Red14.
Immunohistochemistry was performed for Į -smooth muscle actin
(Į -SMA) and glial fibrillary acidic protein (GFAP).
The different pancreatic stellate cell populations will be
evaluated by immunohistochemical staining method (GFAP or
Į -SMA). All tissue samples will be routinely fixed in 4% neutral
formalin and embedded in paraffin. Briefly, 3µm-thick sections
will be cut from paraffin blocks containing representative
pancreatic samples. Paraffin sections will be dewaxed in xylene,
rehydrated through a series of graded alcohols, placed in 10mM
citrate buffer and submitted to heat retrieval using a vapor lock
for 40 minutes. After heating, the slides will be allowed to cool to
room temperature and will be briefly washed with tris-buffered
saline. Endogenous peroxidase activity will be blocked with 3%
hydrogen peroxide in methanol for 5 minutes. Normal serum
(Universal Quick Kit, Novocastra, Newcastle Upon Tyne, United
Kingdom) will be used for 20 minutes to block nonspecific
immunoassaying.
Immunohistochemical staining will be performed using a
streptavidin-biotin peroxidase system (Novocastra Universal
Quick Kit). The following primary antibodies will be incubated
for 2 hours at room temperature: smooth muscle actin (Į -SMA,
1:100, Dako, Glostrup, Denmark) or glial fibrilary protein (GFAP,
1:100, Dako, Glostrup, Denmark). Following washes in phosphate-
buffered saline, biotinylated universal secondary antibody
(Novocastra, Universal Quick Kit) will be applied for 15 minutes.
The sections will be incubated with the streptavidin –biotin
complex reagent (Novocastra, Universal, Quick Kit) for 10
minutes and developed with 3-amino-9-ethyl carbazole
(Vector Laboratories, Burlingame, CA, U.S.A) for 15 minutes. The
sections will be counterstained with Mayer hematoxylin for 1
minute and mounted with Leucognost (Aquatex, Merck, USA).
Positive and negative controls were development. The slides will
be evaluated blindly. GFAP and Į -SMA positive cells, or collagen
staining will be counted in serial immunostained or Siriusred
sections using a point-counting procedure at a magnification
of x400. In the GFAP or Į -SMA immunostained or Siriusred
set of sections, a total of 3000 points per pancreas will be counted
for each animal; each point will be classified as GFAP or Į -SMA
reactive cells, or collagen staining14.
Statistical analysis
The results will be expressed as median and range.
The data were first compared by Kruskal-Wallis oneway analysis
of variance, with the level of significance set at p<0.05. The
Dunn method will be used to compare all groups. The statistical
analysis will be performed with the GraphPad Prism software
(GraphPad Software Inc., San Diego, CA, U.S.A).
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Results
Histopatology
All 21 animals in the control group or did not develop
acute pancreatitis. However the control group had more
inflammatory cells and a significant increase of fibrosis (p<0.05),
as seen in the business of hematoxylin and eosin and Sirius red
(Figure 1A and 1B).
Immunohistochemistry for Stellate Cell Markers
The Į -SMA has been shown to be an excellent marker
for the activated PSC phenotype in vitro. In this study animals
treated, had a lower activity of stellate cells (Figure 1C), when
compared with the control group (Figure 1D and 1E) (p <0.05),
analyzed by Immunohistochemical staining method (GFAP or
Į -SMA). All these results were measured (Figure 2).
FIGURA 1 - Slides stained by hematoxylin and eosin (A) to inflammatory
analysis have showed more neutrophylic inflammatory infiltrate in sample
of control group measured in [purple]. Moreover slides stained by Sirius
red (B) have showed more collagen deposit in the animals of control
group too showed in [eosinofilic]. In the group treated (C) and stained
by immunohistochemical staining method (GFAP or Į -SMA) have less
PSCs activated marked in [blue] compared with animals control (D and
E) which have more PSCs activated measured in [red] (p<0.05)
FIGURE 2 - Comparison of the number of pancreatic stellate cells
marked for alpha-smooth muscle actin (Į -SMA) and fibrillary acidic
protein glial (GFAP), and the percentage of points scored by used.
The (PS),  between the pancreas of control rats treated with lisinopril
and losartan. The  bars represent the mean ± SD. * P <0.001, compared
to the treaties.
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Discussion
Classicaly, the rennin-angiotensin system (RAS) has been
considered a hormonal circulating system. The so-called systemic
or circulating RAS plays a crucial role in the maintenance of
blood pressure15 and electrolyte as well as fuid homeostasis15. This
is mediated through its constrictive actions on vascular smooth
muscle and by its influence on aldosterone secretion from the
adrenal cortex, electrolyte transport in kidney, and on thirst as well
as sodium appetite in the brain. In addition to its actions on the
cardiovascular, renal, and nervous system, the expression of local
RAS components in tissues such as the brain, kidneys, adrenals
and gonads has led to the proposition that these components
may either potentate systemic functions, or have entirely separate
activities meeting the specific needs of these individual tissues.
There is accumulating evidence that changes in tissue/organ-
specific RAS may be associated with the pathophysiology of the
respective tissue/organ functions15.
The physiologically active endocrine product of the
circulating RAS, angiotensin II, is spliced from its liver-derived
precursor angiotensinogen by a sequential action of two critical
enzymes. The first enzyme, rennin, is secreted from juxtaglomerular
cells in the kidney1.
Renin splits a specific leucine-leucine peptide bond in
circulating angiotensinogen, resulting in the formation of the
decapeptide angiotensin I. Angiotensin I is then carried via the blood
to the lungs, where the second enzyme, ACE, removes two amino
acids from the carboxy terminus of angiontensin Ito form the
active octapeptide angiotensin II. ACE is a membrane bound
enzyme anchored on the endothelium of many vascular beds with
the highest concentrations found on the vascular epithelium of
the lung10. Other enzymes may act on angiotensin I or angiotensin
II to yield various active peptide fragments including angiotensin
III and angiotensin IV15.
The final goal of the RAS is the angiotensin II production
that acts through the interaction with two pharmacologically
defined receptor subtypes, namely type 1 (At1) and type 2 (At2)
that are distributed in numerous target tissues and organs14 like
pancreas.
The regulation of tissue RAS is subject to a number of
factors such hormones, ions and stress. Hypoxic stress is known
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to be one such factor which may lead to changes of tissues RAS
expression in, for example, the kidney1, the lung10, the carotid body,
the epididymis and the heart15. Chronic hypoxia elicited a marked
increase in mRNA and protein expression on angiotensinogen12.
It has previously been reported that hypoxia could result in the
decrease of regional blood flow to several tissues including the
pancreas, which may enhance tissue inflammation and injury14.
Beside the pancreatic angiotensinogen, there are also
measured expression changes by acute pancreatitis of the At1 and
At2 receptors. For At1 receptor, experimental pancreatitis caused a
differential mRNA expression for At1a and At1b receptor subtypes
such that At1a subtype was unregulated while At1b subtype
remained unchanged. However, there was no significant increase
of At1 receptor protein in pancreatitis when compared with that in
normal pancreas. The data indicate that the upregulation of At1
receptor, presumably via At1a subtype, but not At1b subtype may
be responsible for the regulation of acute pancreatitis. For At2
receptor, it is more important to demonstrate that pancreatitis
markedly and significantly increased the expression of At2
receptor in the pancreas9. Although the physiological role for
At2 receptor in many tissues, especially in the pancreas remains
unsettled, the role of At2 receptor in the regulation of vascular
injury15 and in the control of apoptosis has been recently addressed.
Taking the data together, it is possible to speculate that the
upregulation of At2 receptor rather than At1 receptor and
activation of locally expressed angiotensinogen in the pancreas
could have a more proeminent role in the regulation of physiology
and possible pathophysiology of pancreatitis14.
Moreover, there was a selective upregulation of mRNAs
for the At1b and At2 receptor subtypes by chronic hypoxia.
Such differential changes of pancreatic RAS components may be
responsible for finely regulating the physiology and adaptation of
the pancreas during chronic hypoxia, but could also trigger
hypoxia-induced pancreatic injury such as acute pancreatitis12.
However, a recent study presented that the protective role At1
receptor antagonist, losartan, could be mediated by the inhibition
of NAD(P)H oxidase-dependent generation of reactive oxygen
species (ROS). Which can be related with antagonized effects of
this drug on acute pancreatitis.
The role of RAS in the inflammatory process was further
evidenced by the ability of an ACE inhibitor to suppress
inflammation and subsequent tissue injury7. Some studies suggest
that losartan, an At1 blocker, and lisinopril, an angiotensin-
converting enzyme (ACE) inhibitor, can inhibit both the liver
fibrosis and portal hypertension occurring in secondary biliary
cirrhosis by inhibiting hepatic stellate cells (HSCs) activation10.
Stellate cells, previously known as Ito cells, vitamin A
storing cells, or lipocytes2 are now know to play a major role in the
production of hepatic fibrosis and are the major source of collagen
and other extracellular matrix proteins in liver disease11. In the
normal liver, stellate cells may be identified by the presence of
fat droplets containing vitamin A10 and by positive staining for
desmin, a cytoskeletal intermediate filament protein. The cells
enlarge, proliferate, and lose the vitamin A – containing lipid
droplets10. Activated stellate cells to recruitment the expression of
extracellular matrix proteins, especially collagen types I and III2, is
increased. Recent studies in the liver have established that stellate
cells, when activated by profibrogenic mediators, play a key role
in hepatic fibrogenesis by synthesizing and secreting increased
amounts of extracellular matrix proteins13,10.
In the normal rat pancreas, stellate cells stain positively
for desmin but do not stain for SMA, indicating a quiescent,
nonactivated state5. Other studies in vitro of cultured pancreatic
stellate cells have demonstrated that these cells exhibit
morphological and functional features similar to cultured hepatic
stellate cells, including positive SMA staining after a period of
time in culture, increased proliferation in response to PDGF,
and increased collagen synthesis in response to TGFȕ 6.
Other authors suggest that PSCs play an important role
in pancreatic fibrogenesis and the cytokines PDGF and TGFȕ 
may be involved in pancreatic fibrogenesis. A major source of TGFȕ 
in the pancreas appears to be pancreatic acinar cells. It possible
that TGFȕ  released by acinar cells secondary to cell injury may be
one of the predominant factors promoting a fibrotic response in
pancreatic stellate cells.
Dual staining techniques demonstrated colocalization of
SMA staining (indicating activated stellate cells) and Sirius Red
staining for collagen protein; this observation provides circumstantial
evidence to support the concept that activated stellate cells may be
involved in collagen production during pancreatic fibrogenesis. In
the rat pancreas, Sirius Red collagen staining was closely associated
with SMA-positive cells in serial sections. The relationship between
pancreatic fibrosis and stellate cells was most clearly demonstrated
in human pancreas by dual staining for collagen and SMA14.
Positive staining for the cytoskeletal protein desmin, a
stellate cell marker, was found to be concentrated within areas
of fibrosis in the pancreas, suggesting increased replication of
stellate cells during fibrogenesis14 and a combination of
immunostaining for SMA and in situ hybridization for procollagen
mRNA demonstrated conclusively that it was activated stellate
cells that were the principal source of collagen production in the
fibrotic pancreas14.
Since PSC have some similarities to hepatic stellate cells
and an intrinsic rennin-angiotensin system is present in the
pancreas and is enhanced in acute pancreatitis and chronic
pancreatic hypoxia, study showed the effects of lisinopril, on
chronic pancreatitis.  In another study, the same authors showed
that candesartan, an angiotensin II receptor antagonist, improved
the chronic inflammation and fibrosis on spontaneously occurring
chronic pancreatitis in rats by suppressing the activation of
pancreatic stellate cells14.
Conclusion
The pancreatic stellate cells strength are involved in
collagen production during acute pancreatitis and possibly that
these cells can become active through the action of angiotensin II
produced by rennin-angiotensin.
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